Effectiveness of anti-HIV in the prevention of perinatal transmission has been established. Assessing the tolerance of drug exposure during pregnancy is of the utmost importance given the number of children exposed. HIV integrase and the recombinase-activating gene enzyme involved in the establishment of the T-lymphocyte repertoire show structural similarity. The inhibition of recombinase-activating (RAG) gene by anti-integrases is observed in vitro, in a variable way according to the molecules. Here, we show that in utero exposure to raltegravir did not alter the T-lymphocyte repertoire of 12 newborns. These reassuring data merit verification for other anti-integrases. ( ClinicalTrial.org NCT04024150).

Download full-text PDF

Source
http://dx.doi.org/10.1097/QAI.0000000000003130DOI Listing

Publication Analysis

Top Keywords

utero exposure
8
hiv integrase
8
t-lymphocyte repertoire
8
report t-cell
4
t-cell receptor
4
receptor repertoire
4
repertoire diversity
4
diversity birth
4
birth utero
4
exposure hiv
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!